Publikationen 2022

Analysis by region of outcomes for patients with advanced renal cell carcinoma treated with cabozantinib or everolimus: a sub-analysis of the METEOR study.
Acta Oncol 2022; 61(1): 52-57;
Schmidinger M, Motzer RJ, Rolland F, Staehler M, Rink M, Retz M, Csoszi T, McCaffrey JA, De Giorgi U, Caserta C, Duran I, Benzaghou F, Clary DO, Albiges L, Choueiri TK, Tannir NM

Single-fraction PSMA-PET- and multiparametric MRI-guided SBRT for Prostate Cancer Local Recurrences.
BJU Int 2022;
Ehret F, Hofmann T, Fürweger C, Kufeld M, Staehler M, Muacevic A, Haidenberger A

Antagonism of α1-adrenoceptors by β3-adrenergic agonists: Structure-function relations of different agonists in prostate smooth muscle contraction.
Biochem Pharmacol 2022;
Huang R, Tamalunas A, Waidelich R, Strittmatter F, Stief CG, Hennenberg M

Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T.
Biomedicines 2022; 10(5):
Unterrainer LM, Beyer L, Zacherl MJ, Gildehaus FJ, Todica A, Kunte SC, Holzgreve A, Sheikh GT, Herlemann A, Casuscelli J, Brendel M, Albert NL, Wenter V, Schmidt-Hegemann NS, Kunz WG, Cyran CC, Ricke J, Stief CG, Bartenstein P, Ilhan H, Unterrainer M

Updated guideline for closure of abdominal wall incisions from the European and American Hernia Societies.
Br J Surg 2022;
Deerenberg EB, Henriksen NA, Antoniou GA, Antoniou SA, Bramer WM, Fischer JP, Fortelny RH, Gök H, Harris HW, Hope W, Horne CM, Jensen TK, Köckerling F, Kretschmer A, López-Cano M, Malcher F, Shao JM, Slieker JC, de Smet GHJ, Stabilini C, Torkington J, Muysoms FE

Combining PSA and PET features to select candidates for salvage lymph node dissection in recurrent prostate cancer.
BJUI Compass 2022; 1– 7.
Bravi, CA, Heidenreich, A, Fossati, N, Gandaglia, G, Suardi, N, Mazzone, E, Stabile A, Cucchiara V, Osmonov D, Juenemann K-P, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat S, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz P, Montorsi F, Briganti A, Pfister D.

Development and Implementation of an Advanced Program for Robotic Treatment of Prostate Cancer-Is Surgical Quality Transferable?
Cancers (Basel) 2022; 14(21)
Sigle A, Jilg CA, Weishaar M, Schlenker B, Stief C, Gratzke C, Grabbert M

Impact of bacillus Calmette-Guerin intravesical therapy on the diagnostic efficacy of The Paris System for Reporting Urinary Cytology in patients with high-grade bladder cancer.
Cancer Cytopathol 2022; 130(4): 294-302;
Hermans J, Jokisch F, Volz Y, Eismann L, Pfitzinger P, Ebner B, Weinhold P, Schlenker B, Stief CG, Tritschler S, Schulz GB

Radiomics for the Prediction of Overall Survival in Patients with Bladder Cancer Prior to Radical Cystectomy.
Cancers (Basel) 2022; 14(18):4449.
Woźnicki P, Laqua FC, Messmer K, Kunz WG, Stief C, Nörenberg D, Schreier A, Wójcik J, Ruebenthaler J, Ingrisch M, Ricke J, Buchner A, Schulz GB, Gresser E.

Expression of Nectin-4 in Variant Histologies of Bladder Cancer and Its Prognostic Value—Need for Biomarker Testing in High-Risk Patients?
Cancers (Basel) 2022; 14(18):4411.
Rodler S, Eismann L, Schlenker B, Casuscelli J, Brinkmann I, Sendelhofert A, Waidelich R, Buchner A, Stief C, Schulz GB, Ledderose S.

Identification of EZH2 as Cancer Stem Cell Marker in Clear Cell Renal Cell Carcinoma and the Anti-Tumor Effect of Epigallocatechin-3-Gallate (EGCG).
Cancers (Basel) 2022; 14(17):4200.
Lyu C, Wang L, Stadlbauer B, Noessner E, Buchner A, Pohla H

Identification of the Tumor Infiltrating Lymphocytes (TILs) Landscape in Pure Squamous Cell Carcinoma of the Bladder.
Cancers (Basel) 2022; 14(16):3999.
Eismann L, Rodler S, Buchner A, Schulz GB, Volz Y, Bischoff R, Ebner B, Westhofen T, Casuscelli J, Waidelich R, Stief C, Schlenker B, Ledderose S

Image-Guided Robotic Radiosurgery for the Treatment of Lung Metastases of Renal Cell Carcinoma-A Retrospective, Single Center Analysis.
Cancers (Basel) 2022; 14(2):356.
Rodler S, Götz M, Mumm JN, Buchner A, Graser A, Casuscelli J, Stief C, Fürweger C, Muacevic A, Staehler M

Molecular Mechanisms Related with Oligometastatic Prostate Cancer-Is It Just a Matter of Numbers?
Cancers (Basel) 2022; 14(3):
Surcel C, Kretschmer A, Mirvald C, Sinescu I, Heidegger I, Tsaur I

How does symptom severity impact clinical outcomes of men with lower urinary tract symptoms after holmium laser enucleation or transurethral resection of the prostate?
Cent European J Urol 2022; 75(4): 387-394.
Tamalunas A, Schott M, Keller P, Atzler M, Ebner B, Buchner A, Stief CG, Magistro G

Reply to: Campodonico F, Introini C. Ref.: Magistro G, Tuog-Linh D, Westhofen T, et al. Occurrence of symptomatic lymphocele after open and robot-assisted radical prostatectomy. Cent European J Urol. 2021; 74: 341-347.
Cent European J Urol 2022; 75(1): 114-115.
Magistro G, Stief CG

Long-term Health-related Quality of Life (HRQOL) After Radical Cystectomy and Urinary Diversion - A Propensity Score-matched Analysis.
Clin Genitourin Cancer 2022;
Volz Y, Eismann L, Pfitzinger P, Westhofen T, Ebner B, Jokisch JF, Buchner A, Schulz GB, Schlenker B, Karl A, Stief CG, Kretschmer A

Propensity Score-Matched Analysis of Single Fraction Robotic Radiosurgery Versus Open Partial Nephrectomy in Renal Cell Carcinoma: Oncological Outcomes.
Cureus 2022; 14(1)
Staehler M, Schuler T, Spek A, Rodler S, Tamalunas A, Fürweger C, Muacevic A

Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence.
Curr Opin Urol 2022; 32(1): 69-84;
Laine C, Gandaglia G, Valerio M, Heidegger I, Tsaur I, Olivier J, Ceci F, van den Bergh RCN, Kretschmer A, Thibault C, Chiu PK, Tilki D, Kasivisvanathan V, Preisser F, Zattoni F, Fankhauser C, Kesch C, Puche-Sanz I, Moschini M, Pradere B, Ploussard G, Marra G, EAU-YAU Prostate Cancer Working Party

Technical Outcome, Clinical Success, and Complications of Low-Milliampere Computed Tomography Fluoroscopy-Guided Drainage of Lymphoceles Following Radical Prostatectomy with Pelvic Lymph Node Dissection.
Diagnostics (Basel) 2022; 12(10)
D'Anastasi M, Ebenberger S, Alghamdi A, Helck A, Herlemann A, Stief C, Khoder W, Trumm CG, Stahl R

Expression of nectin-4 in papillary renal cell carcinoma.
Discov Oncol 2022; 13(1)
Zschäbitz S, Mikuteit M, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Duensing S, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Erlmeier F, Steffens S

68Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results.
Eur J Nucl Med Mol Imaging 2022; 49(5): 1711-1720;
Mittlmeier LM, Todica A, Gildehaus FJ, Unterrainer M, Beyer L, Brendel M, Albert NL, Ledderose ST, Vettermann FJ, Schott M, Rodler S, Marcon J, Ilhan H, Cyran CC, Stief CG, Staehler M, Bartenstein P

Feasibility of [68Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma.
Eur J Nucl Med Mol Imaging 2022;
Unterrainer LM, Lindner S, Eismann L, Casuscelli J, Gildehaus FJ, Bui VN, Albert NL, Holzgreve A, Beyer L, Todica A, Brendel M, Cyran CC, Karl A, Stief CG, Ledderose ST, Unterrainer M, Bartenstein P, Wenter V, Kretschmer A

Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomy.
Eur J Nucl Med Mol Imaging 2022; 49(4): 1417-1428;
Rogowski P, Trapp C, von Bestenbostel R, Eze C, Ganswindt U, Li M, Unterrainer M, Zacherl MJ, Ilhan H, Beyer L, Kretschmer A, Bartenstein P, Stief C, Belka C, Schmidt-Hegemann NS

Aberrant Splice Variants: A Novel Characterization of Clear Cell Renal Cell Carcinoma.
Eur Urol 2022; 82(4): 363-364;
Casuscelli J, Pal SK

Baseline Health-related Quality of Life Predicts Bladder Cancer-specific Survival Following Radical Cystectomy.
Eur Urol Focus 2022;
Westhofen T, Eismann L, Buchner A, Schlenker B, Giessen-Jung C, Becker A, Stief CG, Kretschmer A

Digital Real-world Data Suggest Patient Preference for Tadalafil over Sildenafil in Patients with Erectile Dysfunction.
Eur Urol Focus 2022; 8(3): 794-802;
von Büren M, Rodler S, Wiesenhütter I, Schröder F, Buchner A, Stief C, Gratzke C, Wülfing C, von Büren J

Radiomics Signature Using Manual Versus Automated Segmentation for Lymph Node Staging of Bladder Cancer.
Eur Urol Focus 2022;
Gresser E, Woźnicki P, Messmer K, Schreier A, Kunz WG, Ingrisch M, Stief C, Ricke J, Nörenberg D, Buchner A, Schulz GB

Survival Outcomes After Immediate Radical Cystectomy Versus Conservative Management with Bacillus Calmette-Guérin Among T1 High-grade Micropapillary Bladder Cancer Patients: Results from a Multicentre Collaboration.
Eur Urol Focus 2022; 8(5): 1270-1277;
Lonati C, Baumeister P, Afferi L, Mari A, Minervini A, Krajewski W, Azizi S, Hendricksen K, Martini A, Necchi A, Montorsi F, Briganti A, Colombo R, Tafuri A, Antonelli A, Cerruto MA, Rouprêt M, Masson-Lecomte A, Laukhtina E, D'Andrea D, Shariat SF, Soria F, Marra G, Gontero P, Contieri R, Hurle R, Valiquette AS, Mir MC, Zamboni S, Simeone C, Klatte T, Teoh JY, Yoshida S, Fujii Y, Carando R, Schulz GB, Mordasini L, Mattei A, Moschini M, European Association of Urology Young Academic Urologists (EAU-YAU): Urothelial Carcinoma Working Group

Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy.
Eur Urol Oncol 2022; 5(3): 285-295;
Bravi CA, Droghetti M, Fossati N, Gandaglia G, Suardi N, Mazzone E, Cucchiara V, Scuderi S, Barletta F, Schiavina R, Osmonov D, Juenemann KP, Boeri L, Karnes RJ, Kretschmer A, Buchner A, Stief C, Hiester A, Nini A, Albers P, Devos G, Joniau S, Van Poppel H, Grubmüller B, Shariat SF, Heidenreich A, Pfister D, Tilki D, Graefen M, Gill IS, Mottrie A, Karakiewicz PI, Montorsi F, Briganti A

Reply to Nicolas Mottet, Olivier Rouviere, and Theodorus H. van der Kwast. Incidental Prostate Cancer: A Real Need for Expansion in Guidelines? Eur Urol Oncol. In press: Incidental Prostate Cancer: An Example of How Important Guidelines Are, Especially When Evidence Is Limited.
Eur Urol Oncol 2022; 5(2): 261-262;
Capitanio U, Autorino R, Bandini M, Briganti A, Cheng L, Cooperberg MR, Dehò F, Gallina A, Klotz L, Lane BR, Montironi R, Salonia A, Stief C, Tombal B, Montorsi F

Inhibition of Human Prostate and Bladder Smooth Muscle Contraction, Vasoconstriction of Porcine Renal and Coronary Arteries, and Growth-Related Functions of Prostate Stromal Cells by Presumed Small Molecule Gαq/11 Inhibitor, YM-254890.
Front Physiol 2022; 13():
Tamalunas A, Wendt A, Springer F, Ciotkowska A, Rutz B, Wang R, Huang R, Liu Y, Schulz H, Ledderose S, Magistro G, Stief CG, Hennenberg M

cMET: a prognostic marker in papillary renal cell carcinoma?
Hum Pathol 2022; 121(): 1-10;
Erlmeier F, Bruecher B, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Mondorf Y, Ivanyi P, Mikuteit M, Steffens S, German Network Of Kidney Cancer

Asymptomatic bacteriospermia and infertility-what is the connection?
Infection 2022;
Volz Y, Ebner B, Pfitzinger P, Berg E, Lellig E, Marcon J, Trottmann M, Becker A, Stief CG, Magistro G

Dynamics of urinary and respiratory shedding of Severe acute respiratory syndrome virus 2 (SARS-CoV-2) RNA excludes urine as a relevant source of viral transmission.
Infection 2022; 50(3): 635-642;
Mumm JN, Ledderose S, Ostermann A, Rudelius M, Hellmuth JC, Münchhoff M, Munker D, Scherer C, Volz Y, Ebner B, Giessen-Jung C, Lampert C, Vilsmaier T, Schneider S, Gapp M, Milger-Kneidinger K, Behr J, von Bergwelt-Baildon M, Keppler OT, Stief C, Magistro G, Staehler M, Rodler S

Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population.
Infection 2022;
Tamalunas A, Schott M, Ivanova T, Rodler S, Heinemann V, Stief CG, Casuscelli J

Retrospective evaluation of the impact of non-oncologic chronic drug therapy on the survival in patients with bladder cancer.
Int J Clin Pharm 2022; 44(2): 339-347;
Haimerl L, Strobach D, Mannell H, Stief CG, Buchner A, Karl A, Grimm T

A Pan-Cancer Landscape of ABCG2 across Human Cancers: Friend or Foe?
Int J Mol Sci 2022, 23:15955.
Lyu C, Wang L, Stadlbauer B, Buchner A, Pohla H

Computed-tomography based scoring system predicts outcome for clinical lymph node-positive patients undergoing radical cystectomy.
Int Braz J Urol 2022; 48(1): 89-98;
Eismann L, Rodler S, Tamalunas A, Schulz G, Jokisch F, Volz Y, Pfitzinger P, Schlenker B, Stief C, Solyanik O, Buchner A, Grimm T

Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort.
J Cancer 2022; 13(6): 1706-1712;
Zschäbitz S, Erlmeier F, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Mondorf Y, Hartmann A, Ivanyi P, Steffens S

Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board.
J Cancer Res Clin Oncol 2022;
Heinrich K, Miller-Phillips L, Ziemann F, Hasselmann K, Rühlmann K, Flach M, Biro D, von Bergwelt-Baildon M, Holch J, Herold T, von Baumgarten L, Greif PA, Jeremias I, Wuerstlein R, Casuscelli J, Spitzweg C, Seidensticker M, Renz B, Corradini S, Baumeister P, Goni E, Tufman A, Jung A, Kumbrink J, Kirchner T, Klauschen F, Metzeler KH, Heinemann V, Westphalen CB

Development and pre-clinical test of a phosphorous-32 containing polyetheretherketone foil aiming at urethral stricture prevention by low-dose-rate brachytherapy.
J Contemp Brachytherapy 2022; 14(2): 189-197;
Assmann W, Becker R, Stief C, Sroka R

Development and validation of a triple-LED surgical loupe device for fluorescence-guided resections with 5-ALA.
J Neurosurg 2022; 137(2): 582-590
Suero Molina E, Hellwig SJ, Walke A, Jeibmann A, Stepp H, Stummer W

Inhibition of full smooth muscle contraction in isolated human detrusor tissues by mirabegron is limited to off-target inhibition of neurogenic contractions.
J Pharmacol Exp Ther 2022;
Huang R, Tamalunas A, Waidelich R, Strittmatter F, Stief CG, Hennenberg M

Editorial Comment.
J Urol 2022; 208(4)
Staehler M

The Added Value of Baseline Health-Related Quality of Life in Predicting Survival in High-Risk Prostate Cancer Patients Following Radical Prostatectomy.
J Urol 2022;
Westhofen T, Buchner A, Kasivisvanathan V, Lennartz S, Schlenker B, Becker A, Stief CG, Kretschmer A

The Detection of Prostate Cancer with Magnetic Resonance Imaging-Targeted Prostate Biopsies is Superior with the Transperineal vs the Transrectal Approach. A European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi-Institutional Study.
J Urol 2022; 208(4): 830-837
Zattoni F, Marra G, Kasivisvanathan V, Grummet J, Nandurkar R, Ploussard G, Olivier J, Chiu PK, Valerio M, Gontero P, Guo H, Zhuang J, Barletta F, Leni R, Frydenberg M, Moon D, Hanegbi U, Landaumailto A, Snow R, Apfelbeck M, Kretschmer A, van den Bergh R, Novara G, Briganti A, Dal Moro F, Gandaglia G

Endovenous laser ablation using laser systems emitting at wavelengths > 1900 nm: a systematic review.
Lasers Med Sci 2022;
Setia A, Schmedt CG, Sroka R

Development of a microstructured tissue phantom with adaptable optical properties for use with microscopes and fluorescence lifetime imaging systems.
Lasers Surg Med 2022;
Freymüller C, Ströbl S, Aumiller M, Eisel M, Sroka R, Rühm A

Evaluation of hyperspectral imaging to quantify perfusion changes during the modified Allen test.
Lasers Surg Med 2022; 54(2): 245-255;
Linek M, Felicio-Briegel A, Freymüller C, Rühm A, Englhard AS, Sroka R, Volgger V

Homogeneously Emitting, Mechanically Stable, and Efficient fs-Laser-Machined Fiber Diffusers for Medical Applications.
Lasers Surg Med 2022; 54(4): 588-599;
Ströbl S, Wäger F, Domke M, Rühm A, Sroka R

Safety and efficacy of endovenous laser ablation (EVLA) using 1940 nm and radial emitting fiber: 3-year results of a prospective, non-randomized study and comparison with 1470 nm.
Lasers Surg Med 2022; 54(4): 511-522;
Setia A, Schmedt CG, Beisswenger A, Dikic S, Demhasaj S, Setia O, Schmitz-Rixen T, Sroka R

Permixon®, hexane-extracted Serenoa repens, inhibits human prostate and bladder smooth muscle contraction and exerts growth-related functions in human prostate stromal cells.
Life Sci 2022; 308()
Tamalunas A, Wendt A, Springer F, Vigodski V, Ciotkowska A, Rutz B, Wang R, Huang R, Liu Y, Schulz H, Ledderose S, Kolben T, Magistro G, Stief CG, Hennenberg M

Holmium laser enucleation of the prostate: A truly size-independent method?
Low Urin Tract Symptoms 2022; 14(1): 17-26;
Tamalunas A, Westhofen T, Schott M, Keller P, Atzler M, Stief CG, Magistro G

Two Polyketides Intertwined in Complex Regulation: Posttranscriptional CsrA-Mediated Control of Colibactin and Yersiniabactin Synthesis in Escherichia coli.
MBio 2022;
Rehm N, Wallenstein A, Keizers M, Homburg S, Magistro G, Chagneau CV, Klimek H, Revelles O, Helloin E, Putze J, Nougayrède JP, Schubert S, Oswald E, Dobrindt U

Update zum Harnblasenkrebs.
MMW Fortschr Med 2022; 164(12):
Stief CG

Urologische Notfälle: Was Sie wissen sollten.
MMW Fortschr Med 2022; 164(15)
Stief CG

[Acute bacterial prostatitis].
MMW Fortschr Med 2022; 164(15): 41-43;
Ivanova T, Stief CG, Magistro G

[Common disease with new therapeutic options].
MMW Fortschr Med 2022; 164(1): 50-58;
Ebner B, Atzler M, Keller P, Götz M, Tamalunas A, Westhofen T, Stief CG, Magistro G

[Initial symptoms and diagnostics of bladder cancer].
MMW Fortschr Med 2022; 164(12): 36-39;
Eismann L, Ebner B, Volz Y, Bischoff R, Stief CG, Schulz GB

[Sonography of the genitourinary system].
MMW Fortschr Med 2022; 164(21-22): 54-63;
Berg EK, Clevert DA, Apfelbeck M, Stief CG, Chaloupka M

[Surgical and systemic therapy of bladder cancer].
MMW Fortschr Med 2022; 164(12): 40-42;
Ebner B, Eismann L, Volz Y, Bischoff R, Stief CG, Schulz GB

[Tantalizing lower abdomen pain].
MMW Fortschr Med 2022; 164(15): 36-37;
Keller P, Stief CG, Jokisch JF

[Testicular torsion - etiology, diagnostic pathway and treatment].
MMW Fortschr Med 2022; 164(15): 39-40;
Berg EK, Stief CG, Marcon J

[Treatment of infected hydronephrosis].
MMW Fortschr Med 2022; 164(15):
Eismann L, Stief CG, Chaloupka M

Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.
Med Oncol 2022; 39(6)
Fey T, Erickson N, Stahler A, Muenchhoff M, Keppler OT, Ruehlmann K, Krauss-Pfeiffer G, Steinberg H, Graf A, Krebs S, Blum H, Khatamzas E, Seynstahl S, Casuscelli J, Markwardt D, Forstpointner R, Schinköthe T, von Bergwelt-Baildon M, Heinemann V

Molecular characterization of renal cell carcinoma tumors from a phase III anti-angiogenic adjuvant therapy trial.
Nat Commun 2022; 13(1)
Motzer RJ, Martini JF, Mu XJ, Staehler M, George DJ, Valota O, Lin X, Pandha HS, Ching KA, Ravaud A

The COVID-19 pandemic - what have urologists learned?
Nat Rev Urol 2022;
Ebner B, Volz Y, Mumm JN, Stief CG, Magistro G

Inhibition of neurogenic contractions in renal arteries and of cholinergic contractions in coronary arteries by the presumed inhibitor of ADP-ribosylation factor 6, NAV2729.
Naunyn Schmiedebergs Arch Pharmacol 2022; 395(4): 471-485;
Huang R, Li B, Tamalunas A, Waidelich R, Stief CG, Hennenberg M

The burden of fear of cancer recurrence in genitourinary cancers - a prospective study (NCT04535921).
Oncol Res Treat 2022 Sep 26. doi: 10.1159/000527161.
Volz Y, Troost J, Eismann L, Jokisch F, Schulz GB, Schlenker B, Kretschmer A, Staehler M, Boeck S, Waidelich R, Buchner A, Stief CG, Rodler S

The prognostic impact of Claudin 6 in papillary renal cell carcinoma.
Pathol Res Pract 2022; 231(): ;
Mikuteit M, Zschäbitz S, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief C, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Steffens S, Erlmeier F

Gender Bias in Urology: How Do Patients Really Choose Their Urologist?
Patient Prefer Adherence 2022; 16:3001-3013
Tamalunas A, Lenau P, Stadelmeier LF, Mumm JN, Vilsmaier T, Höhn H, Mumm ML, Waidelich R, Casuscelli J, Magistro G, Buchner A, Kolben T, Stief C, Hennenberg M

The role of shikonin in improving 5-aminolevulinic acid-based photodynamic therapy and chemotherapy on glioblastoma stem cells.
Photodiagnosis Photodyn Ther 2022;
Werner M, Lyu C, Stadlbauer B, Schrader I, Buchner A, Stepp H, Sroka R, Pohla H

Inhibition of human prostate smooth muscle contraction by the inhibitors of protein kinase C, GF109203X, and Go6983.
Prostate 2022; 82(1): 59-77;
Huang R, Liu Y, Li B, Wang R, Tamalunas A, Waidelich R, Strittmatter F, Stief CG, Hennenberg M

Active surveillance in intermediate-risk prostate cancer with PSA 10-20 ng/mL: pathological outcome analysis of a population-level database.
Prostate Cancer Prostatic Dis 2022; 25(4): 690-693;
Lonergan PE, Jeong CW, Washington SL, Herlemann A, Gomez SL, Carroll PR, Cooperberg MR

Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics.
Psychooncology 2022; 31(5): 770-778;
Pichler T, Marten-Mittag B, Hermelink K, Telzerow E, Frank T, Ackermann U, Belka C, Combs SE, Gratzke C, Gschwend J, Harbeck N, Heinemann V, Herkommer K, Kiechle M, Mahner S, Pigorsch S, Rauch J, Stief C, Mumm F, Heußner P, Herschbach P, Dinkel A

Performance variability of radiomics machine learning models for the detection of clinically significant prostate cancer in heterogeneous MRI datasets.
Quant Imaging Med Surg 2022; 12(11): 4990-5003
Gresser E, Schachtner B, Stüber AT, Solyanik O, Schreier A, Huber T, Froelich MF, Magistro G, Kretschmer A, Stief C, Ricke J, Ingrisch M, Nörenberg D

Outcomes and Prognostic Factors of Patients with Urothelial Carcinoma Undergoing Radical Cystectomy and pT0 in the Final Histology Without Neoadjuvant Chemotherapy.
Res Rep Urol 2022; 14(): 281-290;
Rodler S, Buchner A, Eismann L, Schulz GB, Marcon J, Ledderose S, Schlenker B, Stief CG, Karl A, Jokisch JF

Multicentric comparative analysis of Retzius versus Retzius sparing robotic assisted simple prostatectomy in the management of large prostate glands.
Scand J Urol 2022; 56(2): 119-125;
Surcel C, Najjar S, Labanaris A, Zugor V, Kajaia D, Heidegger I, Sinescu I, Gandaglia G, Kretschmer A, Mirvald C

Validation of a CE-IVD, urine exosomal RNA expression assay for risk assessment of prostate cancer prior to biopsy.
Sci Rep 2022; 12(1):
Kretschmer A, Kajau H, Margolis E, Tutrone R, Grimm T, Trottmann M, Stief C, Stoll G, Fischer CA, Flinspach C, Albrecht A, Meyer L, Priewasser T, Enderle D, Müller R, Torkler P, Alter J, Skog J, Noerholm M

RAS-NOTECHS: validity and reliability of a tool for measuring non-technical skills in robotic-assisted surgery settings.
Surg Endosc 2022; 36(3): 1916-1926;
Schreyer J, Koch A, Herlemann A, Becker A, Schlenker B, Catchpole K, Weigl M

Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review.
Ther Adv Med Oncol 2022; 14()
Heidegger I, Kesch C, Kretschmer A, Tsaur I, Ceci F, Valerio M, Tilki D, Marra G, Preisser F, Fankhauser CD, Zattoni F, Chiu P, Puche-Sanz I, Olivier J, van den Bergh RCN, Kasivisvanathan V, Pircher A, Virgolini I, Gandaglia G

APOBEC-mediated mutagenesis is a favorable predictor of prognosis and immunotherapy for bladder cancer patients: evidence from pan-cancer analysis and multiple databases.
Theranostics 2022; 12(9): 4181-4199;
Shi R, Wang X, Wu Y, Xu B, Zhao T, Trapp C, Wang X, Unger K, Zhou C, Lu S, Buchner A, Schulz GB, Cao F, Belka C, Su C, Li M, Shu Y

Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy.
Urol Int 2022; (): 1-8;
Eismann L, Bohn L, Buchner A, Casuscelli J, Volz Y, Weinhold P, Wülfing C, Waidelich R, Stief CG, Schlenker B, Rodler S

Clinical Evaluation of Single-Use, Fiber-Optic, and Digital Ureterorenoscopes in the Treatment of Kidney Stones.
Urol Int 2022; (): 1-6;
Eismann L, Kretschmer A, Alghamdi A, Eisel M, Sroka R, Stief CG, Strittmatter F

Clinical Implication of Borderline CT-Morphological Metastatic Spread in Bladder Cancer: What You See Is Not Always What You Got.
Urol Int 2022; (): 1-10;
Weinhold P, Jokisch F, Schulz GB, Buchner A, Kazmierczak PM, Kretschmer A, Schlenker B, Karl A, Stief CG, Grimm T

Prognostic Value of Pretreatment Inflammatory Markers in Patients Receiving Radical Cystectomy for Urothelial Bladder Cancer: Does Age Matter?
Urol Int 2022; (): 1-8;
Volz Y, Pfitzinger PL, Eismann L, Ebner B, Jokisch F, Schulz GB, Buchner A, Schlenker B, Stief CG, Rodler S

The Prognostic Impact of PD-L2 in Papillary Renal-Cell Carcinoma.
Urol Int 2022; (): 1-9;
Mondorf Y, Mikuteit M, Ivanyi P, Stöhr C, Herrmann E, Polifka I, Agaimy A, Trojan L, Ströbel P, Becker F, Wülfing C, Barth P, Stöckle M, Staehler M, Stief CG, Haferkamp A, Hohenfellner M, Macher-Göppinger S, Wullich B, Noldus J, Brenner W, Roos FC, Walter B, Otto W, Burger M, Schrader AJ, Hartmann A, Steffens S, Erlmeier F

Dynamic contrast-enhanced CT-derived blood flow measurements enable early prediction of long term outcome in metastatic renal cell cancer patients on antiangiogenic treatment.
Urol Oncol 2022; 40(1): 13.e1-13.e8;
Spek A, Graser A, Casuscelli J, Szabados B, Rodler S, Marcon J, Stief C, Staehler M

[4/f with recurrent pyelonephritis : Preparation for the medical specialist examination: part 20].
Urologe A 2022; 61(Suppl 2): 63-67;
Pfitzinger PL, Becker K, Heinrich M, Lisec K, Pfluger T, Kammerer B, Stredele RJF

[Imaging update for urologists : Modern diagnostics in hospitals and medical practices].
Urologe A 2022; 61(4): 355-356;
Hadaschik B, Stief C

[Sonography of the prostate : Relevance for urologists in daily clinical routine].
Urologe A 2022;
Apfelbeck M, Clevert DA, Stief CG, Chaloupka M

[Urinary diversion for acute epididymitis : Transurethral or suprapubic catheter?]
Urologe A 2022;
Magistro G, Stief CG, Wagenlehner FME, Pilatz A

[Promoting women in urology using the example of habilitation].
Urologie 2022; 61(9): 951-958;
Welte MN, Knipper S, Siech C, Greiser EM, Wiemer L, Müller K, Bellut L, Walach MT, Herlemann A, Weinberger S

[Special diagnostics in pediatric urology-Nuclear medicine diagnostics, advanced diagnostics for bladder voiding disorders and imaging diagnostics in the operating room : Tips for the practice part 2].
Urologie 2022; 61(8): 869-878;
Pfitzinger PL, Eismann L, Lellig K, Becker K, Heinrich M, Zeller C, Lisec K, Clevert DA, Pfluger T, Stief C, Kammer B, Stredele RJF

[Special diagnostics in pediatric urology-Ultrasound, VCUG, CT and MRI : Part 1: tips for the practice].
Urologie 2022; 61(7): 782-791;
Pfitzinger PL, Stredele RJF, Eismann L, Lellig K, Becker K, Heinrich M, Zeller C, Lisec K, Clevert DA, Pfluger T, Stief C, Kammer B

AUTHOR REPLY.
Urology 2022; 159(): 189-190;
Westhofen T, Stief CG, Magistro G

Spinal Versus General Anesthesia for Holmium Laser Enucleation of the Prostate of High-risk Patients - A Propensity-score-matched-analysis.
Urology 2022; 159(): 182-190;
Westhofen T, Schott M, Keller P, Tamalunas A, Atzler M, Ebner B, Schultheiß M, Damm A, Kowalski C, Stief CG, Magistro G

Heterogenous NECTIN4 expression in urothelial high-risk non-muscle-invasive bladder cancer.
Virchows Arch 2022;
Garczyk S, Degener S, Bischoff F, Schnitzler T, Salz A, Golz R, Buchner A, Schulz GB, Schneider U, Gaisa NT, Knüchel R

Accuracy and prognostic value of radiological lymph node features in variant histologies of bladder cancer.
World J Urol 2022;
Rodler S, Solyanik O, Ingenerf M, Fabritius M, Schulz GB, Jokisch F, Volz Y, Westhofen T, Ebner B, Casuscelli J, Kretschmer A, Waidelich R, Schlenker B, Stief C, Buchner A, Eismann L

Polyethylene glycol-coated collagen patch (hemopatch®) in open partial nephrectomy.
World J Urol 2022; 40(1): 127-132;
Staehler M, Rodler S, Schott M, Casuscelli J, Stief C, Spek A, Schlenker B

Pre-diagnosis urine exosomal RNA (ExoDx EPI score) is associated with post-prostatectomy pathology outcome.
World J Urol 2022; 40(4): 983-989
Kretschmer A, Tutrone R, Alter J, Berg E, Fischer C, Kumar S, Torkler P, Tadigotla V, Donovan M, Sant G, Skog J, Noerholm M

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group.
World J Urol 2022;
Grünwald V, Bergmann L, Brehmer B, Eberhardt B, Kastrati K, Gauler T, Gehbauer G, Gschwend J, Johannsen M, Klotz T, Protzel C, Schenck M, Staehler M